ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2022 American Transplant Congress

TOPIC: Clinical Science

  • Consent to Organ Offers from Public Health Service Increased Risk Donors Decreases Time to Transplant and Waitlist Mortality

    Y. Kelly, A. Zarinsefat, M. Tavakol, A. Shui, C. Huang, J. P. Roberts

  • Contacts Between Organ Donor Families and Their Recipients is Therapeutic for Both Sides in Most Cases

    R. Green

  • Controlling Instability at Reperfusion: Another Benefit of Normothermic Machine Perfusion Using OCS Liver

    C. S. Hwang1, C. Shi2, M. Patel1, J. Shah1, L. DeGregorio1, S. Hanish1, Y. Kadakia3, U. Chaudhary3, E. Okoro2, S. Cheruku2, P. Lahsaei2, P. Vagefi1, M. MacConmara4

  • Conversion from Immediate to Extended-Release Tacrolimus (LCP-Tac) Six Months After Renal Transplantation Optimizes Safety and Efficacy

    S. P. Patel, F. Bartlett, T. Sprague, J. Newman, E. Andrade, N. Rao, N. Patel, D. Dubay, V. Rohan, M. Casey, D. Taber

  • Conversion of Tacrolimus Immediate Release to LCP Tacrolimus in Obese Kidney Transplant Recipients

    J. Newman, N. Patel, S. Patel, T. Sprague, E. Andrade, N. Rao, F. Bartlett, D. DuBay, V. Rohan, M. Casey, D. Taber

  • Conversion to Belatacept for Calcineurin Inhibitor Toxicities

    S. S. Patel, P. Jadav, M. Sekulic, S. Kudose, I. Batal, S. Mohan, R. Crew

  • Conversion to Everolimus-Based Immunosuppression Regimen with Calcineurin Inhibitor Reduction Ameliorates Histological Damage in Kidney Transplant Recipients with Calcineurin Inhibitor-Induced Nephrotoxicity

    K. Hotta, N. Iwahara, T. Tanabe, N. Shinohara

  • Coordinated, Multimodal Care After Kidney Transplantation Improves Graft Survival and Cardiovascular Risks – Results of the Kidney Transplantation 360°- Study (ktx360°)

    L. Pape1, M. DeZwaan2, V. Kliem3, H. Nolting4, J. Wolff4, U. Tegtbur5, M. Schiffer6

  • Correction of Hyperoxaluria in a Primary Hyperoxaluria Type 2 Patient After Simultaneous Liver Kidney Transplantation

    K. Genena, D. Milliner, J. Lieske

  • Correlating Histology, Immunohistochemical, & Serologic Data in Heart Transplant Recipients: Implications for Molecular Diagnostic Assays

    P. Randhawa, Y. Huang

  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 137
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences